Science Explorer Back to mapMap

Most cited papers from Selventa (United States)

What are the most cited papers from Selventa (United States)?

The most cited paper from Selventa (United States) is "Differential Effector Engagement by Oncogenic KRAS" (Tina L. Yuan et al., 2018), with 152 citations. Next come "Causal biological network database: a comprehensive platform of causal biological network models focused on the pulmonary and vascular systems" (107) and "Assessment of network perturbation amplitudes by applying high-throughput data to causal biological networks" (103).

Showing 39 of 39 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Differential Effector Engagement by Oncogenic KRAS Tina L. Yuan et al. · Cell Reports Open access Feb 2018 152
2 Causal biological network database: a comprehensive platform of causal biological network models focused on the pulmonary and vascular systems Stéphanie Boué, Marja Talikka, Jurjen W. Westra et al. · Database Open access 2015 107
3 Assessment of network perturbation amplitudes by applying high-throughput data to causal biological networks Florian Pierre Martin, Ty M. Thomson, Alain Sewer et al. · BMC Systems Biology Open access 31 May 2012 103
4 Reverse causal reasoning: applying qualitative causal knowledge to the interpretation of high-throughput data Natalie L. Catlett, Anthony J Bargnesi, Stephen Ungerer et al. · BMC Bioinformatics Open access 23 Nov 2013 103
5 A network-based approach to quantifying the impact of biologically active substances Julia Hoeng, Renée Deehan, Dexter R. Pratt et al. · Drug Discovery Today 7 Dec 2011 99
6 Verification of systems biology research in the age of collaborative competition Pablo Meyer et al. · Nature Biotechnology Open access Sep 2011 98
7 A computable cellular stress network model for non-diseased pulmonary and cardiovascular tissue Walter K. Schlage, Jurjen W. Westra, Stephan Gebel et al. · BMC Systems Biology Open access 19 Oct 2011 78
8 Construction of a computable cell proliferation network focused on non-diseased lung cells Jurjen W. Westra, Walter K. Schlage, Brian P. Frushour et al. · BMC Systems Biology Open access 2 Jul 2011 65
9 Mechanisms of Pinometostat (EPZ-5676) Treatment–Emergent Resistance in MLL -Rearranged Leukemia Carly T. Campbell, Jessica N. Haladyna, David A. Drubin et al. · Molecular Cancer Therapeutics 20 Apr 2017 64
10 Quantitative assessment of biological impact using transcriptomic data and mechanistic network models Ty M. Thomson, Alain Sewer, Florian Pierre Martin et al. · Toxicology and Applied Pharmacology Open access 7 Aug 2013 62
11 Construction of a Computable Network Model for DNA Damage, Autophagy, Cell Death, and Senescence Stephan Gebel, Rosemarie B. Lichtner, Brian P. Frushour et al. · Bioinformatics and Biology Insights Open access 2013 60
12 A Modular Cell-Type Focused Inflammatory Process Network Model for Non-Diseased Pulmonary Tissue Jurjen W. Westra, Walter K. Schlage, Arnd Hengstermann et al. · Bioinformatics and Biology Insights Open access 2013 55
13 Pressing needs of biomedical text mining in biocuration and beyond: opportunities and challenges Ayush Singhal, Robert Leaman, Natalie L. Catlett et al. · Database Open access 2016 47
14 Genes Associated with Intestinal Permeability in Ulcerative Colitis: Changes in Expression Following Infliximab Therapy Gary P. Toedter, Katherine Li, Sarah L. Sague et al. · Inflammatory Bowel Diseases 5 Jan 2012 44
15 Enhancement of COPD biological networks using a web-based collaboration interface The sbv IMPROVER project team (in alphabetical order) et al. · F1000Research Open access 20 May 2015 35
16 Utilization of Causal Reasoning of Hepatic Gene Expression in Rats to Identify Molecular Pathways of Idiosyncratic Drug-Induced Liver Injury Daphna Laifenfeld, Luping Qiu, Rachel L. Swiss et al. · Toxicological Sciences Open access 17 Oct 2013 33
17 Blood-based identification of non-responders to anti-TNF therapy in rheumatoid arthritis Ty M. Thomson, Reynald M. Lescarbeau, David A. Drubin et al. · BMC Medical Genomics Open access 2 Jun 2015 32
18 On Crowd-verification of Biological Networks Sam Ansari, Jean Binder, Stéphanie Boué et al. · Bioinformatics and Biology Insights Open access 2013 28
19 Training and evaluation corpora for the extraction of causal relationships encoded in biological expression language (BEL) Juliane Fluck, Sumit Madan, Sam Ansari et al. · Database Open access 2016 27
20 A vascular biology network model focused on inflammatory processes to investigate atherogenesis and plaque instability Héctor De León, Stéphanie Boué, Walter K. Schlage et al. · Journal of Translational Medicine Open access 2014 27
21 The Adverse Outcome Pathway for Oxidative Stress-Mediated EGFR Activation Leading to Decreased Lung Function Karsta Luettich, Marja Talikka, Frazer Lowe et al. · Applied In Vitro Toxicology Open access Mar 2017 25
22 Early Patient Stratification and Predictive Biomarkers in Drug Discovery and Development Daphna Laifenfeld, David A. Drubin, Natalie L. Catlett et al. · Advances in experimental medicine and biology Book chapter 18 Nov 2011 23
23 Targeting Tumor Cells with Anti-CD44 Antibody Triggers Macrophage-Mediated Immune Modulatory Effects in a Cancer Xenograft Model Daniela Maisel, Fabian Birzele, Edgar Voß et al. · PLoS ONE Open access 27 Jul 2016 22
24 Transcriptional profiling and targeted proteomics reveals common molecular changes associated with cigarette smoke-induced lung emphysema development in five susceptible mouse strains Maciej Cabanski, Brett Fields, Stéphanie Boué et al. · Inflammation Research Open access 11 May 2015 21
25 Systems diagnostics: anticipating the next generation of diagnostic tests based on mechanistic insight into disease David A. Fryburg, Diane H. Song, Daphna Laifenfeld et al. · Drug Discovery Today 16 Jul 2013 20
26 Comparative Transcriptional Network Modeling of Three PPAR-α/γ Co-Agonists Reveals Distinct Metabolic Gene Signatures in Primary Human Hepatocytes Renée Deehan, Pia Maerz-Weiss, Natalie L. Catlett et al. · PLoS ONE Open access 13 Apr 2012 19
27 Community-Reviewed Biological Network Models for Toxicology and Drug Discovery Applications Aishwarya Alex Namasivayam et al. · Gene Regulation and Systems Biology Open access 2016 18
28 Development of an Adverse Outcome Pathway for the Onset of Hypertension by Oxidative Stress-Mediated Perturbation of Endothelial Nitric Oxide Bioavailability Frazer Lowe, Karsta Luettich, Marja Talikka et al. · Applied In Vitro Toxicology Open access Mar 2017 17
29 A decade of Systems Biology: where are we and where are we going to? Manuel C. Peitsch, David de Graaf · Drug Discovery Today 13 Jun 2013 11
30 An algorithm for score aggregation over causal biological networks based on random walk sampling Dmitry M. Vasilyev, Ty M. Thomson, Brian P. Frushour et al. · BMC Research Notes Open access 11 Aug 2014 6
31 REPUTATION-BASED COLLABORATIVE NETWORK BIOLOGY The sbv IMPROVER project team, Jean Binder, Stéphanie Boué et al. Conference paper Nov 2014 4
32 Multi-omic biomarkers unlock the potential of diagnostic testing. David de Graaf · PubMed Aug 2013 2
33 A Novel Mechanistic Biomarker Panel Predicts Response to Infliximab in Patients with Crohnʼs Disease Michael P. Macoritto, Vy Hoang, Timothy M. Thomson et al. · Inflammatory Bowel Diseases Open access Dec 2012 2
34 Using a Crowdsourcing Approach for Network Verification Natalia Boukharov, Jennifer S. Park · Methods in pharmacology and toxicology Book chapter 2015 1
35 President's Column Tim Dodge · The Southeastern Librarian Open access 15 Feb 2019 0
36 Site-Specific, SEM Semiconductor Sample Preparation With 0.5 μm Accuracy Reza Alani, Efrat M. Raz · EDFA Technical Articles May 2001 0
37 Sharing systems toxicology data for inhalation toxicology Stéphanie Boué, Barry J. Hardy, Wayland J. Hayes et al. · Toxicology Letters Oct 2016 0
38 Decision-Making Tools in Rheumatoid Arthritis Renée Deehan Kenney · Inside Precision Medicine Sep 2015 0
39 Company Profile: Selventa, Inc. David A. Fryburg, Louis J Latino, John Tagliamonte et al. · Personalized Medicine Aug 2012 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.